Publications
Detailed Information
RAD001 shows activity against gastric cancer cells and overcomes 5-FU resistance by downregulating thymidylate synthase
Cited 38 time in
Web of Science
Cited 43 time in Scopus
- Authors
- Issue Date
- 2010-12-18
- Publisher
- Elsevier BV
- Citation
- Cancer Letters, Vol.299 No.1, pp.22-28
- Abstract
- We evaluated RAD001 an inhibitor of the mammalian target of rapamycin (mTOR) in human gastric cancer cell lines and determined the molecular mechanisms RAD001 has marked growth inhibitory activity against the SNU-1 and SNU-216 cells It inhibited phosphorylation of mTOR and S6 K and induced Cl cell cycle arrest Synergistic growth inhibitory effects in combination with 5-fluorouracil (5-FU) was identified Furthermore RAD001 conferred sensitivity to 5-FU-resistant cell lines by downregulating thymidylate synthase (TS) In conclusion RAD001 showed growth inhibitory activity against gastric cancer cells and acted synergistically with cytotoxic agents such as 5-FU by downregulating TS (C) 2010 Elsevier Ireland Ltd All rights reserved
- ISSN
- 0304-3835
- Language
- English
- Files in This Item:
- There are no files associated with this item.
Item View & Download Count
Items in S-Space are protected by copyright, with all rights reserved, unless otherwise indicated.